Find a Physician | Courier | Events Calendar | About Us | Clinical Trials
Select a Cancer Type:

Postdoctoral Training Program in Cancer Nanotechnology

The T32 Postdoctoral Training Program in Cancer Nanotechnology is an NCI-funded, two-year program that consists of research, educational, and career development components, and that will prepare participants for academic and related careers in translational cancer nanotechnology.

Fellows enrolled in the training program will acquire the skills and knowledge to design cancer nanomaterials, to investigate their biological properties, and to evaluate their safety and efficacy. In addition to the Lurie Cancer Center, Northwestern University’s International Institute for Nanotechnology, the Simpson Querry Institute for BioNanotechnology in Medicine, and an NCI-funded Center of Cancer Nanotechnology Excellence all provide resources for the training program.

Program Director:
Gayle Woloschak, PhD, Professor, Department of Radiation Oncology, Feinberg School of Medicine

Program Co-Director:
Andrew Larson, PhD, Professor, Department of Radiology, Feinberg School of Medicine

Program Administrator:
Benette Phillips, PhD, Research Assistant Professor, Lurie Cancer Center

Research Mentors

Vadim Backman, PhD
Professor, Biomedical Engineering
Novel optical methods to interrogate cellular nanoscale architecture
Chonghui Cheng, MD, PhD
Assistant Professor, Medicine
Detection of live circulating breast tumor cells using NanoFlares
Susan Clare, MD, PhD
Research Associate Professor, Surgery
Nano-based therapies for breast cancer metastases to the brain
Vinayak Dravid, PhD
Professor, Materials Science and Engineering
Magnetic nanoconstructs that can simultaneously detect and treat tumors
Leo Gordon, MD
Professor, Medicine
Synthetic HDL gold nanoparticles to treat B-cell lymphomas
John Kessler, MD
Professor, Neurology
DNA-peptide nanotubes that enhance neural stem cell differentiation
Andrew Larson, PhD
Professor, Radiology
Nanoparticles to plan and monitor radioembolization of liver tumors
Maciej Lesniak, MD
Professor and Chair, Neurological Surgery
Nanomaterials to image and treat glioblastomas
Thomas Meade, PhD
Professor, Chemistry
Nanomaterials for multimodal imaging of tumors
Chad Mirkin, PhD
Professor, Chemistry
Design of nanoparticle-based tools for cancer diagnosis and for therapeutic modulation of gene expression
Milan Mrksich, PhD
Professor, Biomedical Engineering
Bioactive material-based assays to study cancer cell behavior
SonBinh Nguyen, PhD
Professor, Chemistry
Polymer-based nanoparticles to deliver cancer therapeutics
Thomas O'Halloran, PhD
Professor, Chemistry
Tumor-targeted nanobins to treat breast and ovarian cancer
Teri Odom, PhD
Professor, Chemistry
Gold nanostars for nuclear-targeted therapy
Amy Paller, MD
Professor, Dermatology
Spherical nucleic acid nanoconstructs for skin cancer treatment
Alexander Stegh, PhD
Assistant Professor, Neurology
Polyvalent RNAi gold nanoparticles to treat gliomas
Samuel Stupp, PhD
Professor, Materials Science and Engineering
Biomedical applications of bioactive nanostructures
C. Shad Thaxton, MD, PhD
Assistant Professor, Urology
Nanoparticle therapeutics, imaging agents, and biosensors
Gayle Woloschak, PhD
Professor, Radiation Oncology
Photoactivatable titanium dioxide bionanocomposites for anti-cancer applications

Qualified PhDs and MDs are encouraged to apply. Applicants must be U.S. citizens or permanent residents. For further information about the program and application instructions, please contact the Program Director, Gayle Woloschak, PhD, or the Program Administrator, Benette Phillips, PhD,